MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
MAT2A抑制剂AG-270/S095033治疗晚期恶性肿瘤患者:一项I期试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-55316-5
Gounder, Mrinal; Johnson, Melissa; Heist, Rebecca S; Shapiro, Geoffrey I; Postel-Vinay, Sophie; Wilson, Frederick H; Garralda, Elena; Wulf, Gerburg; Almon, Caroline; Nabhan, Salah; Aguado-Fraile, Elia; He, Peng; Romagnoli, Mathilde; Hossain, Mohammad; Narayanaswamy, Rohini; Sadou-Dubourgnoux, Amel; Cooper, Michael; Askoxylakis, Vasileios; Burris, Howard A; Tabernero, Josep